Advertisement

Topics

The Bachmann-Strauss Dystonia and Parkinson Foundation Company Profile

23:58 EDT 17th June 2018 | BioPortfolio

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to provide medical and patient information. Lou Bachmann (1916-2000) and Bonnie Strauss founded The Bachmann-Strauss Dystonia & Parkinson Foundation (BSDPF) in 1995 as a nonprofit 501(c)3. The Foundation was started to encourage new scientific research in the fields of dystonia and Parkinson's disease and to heighten awareness about the diseases. The Foundation is also the leading organization actively looking at the interface between dystonia and Parkinson’s disease. Early stages of scientific research are often the hardest to fund. Following a similar concept to that of a "venture capital" fund, seed money is funded through annual grants, which help to leverage new ideas and advances in the fields. To date, the Foundation has raised over $35 million dollars and funded 235 grants in the U.S. and abroad.


News Articles [962 Associated News Articles listed on BioPortfolio]

The Michael J. Fox Foundation Launches Parkinson’s Clinical Trial Platform

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launched an educational suite dubbed the “Parkinson’s Clinical Trial Companion.”

Bachmann Welser firma un Memorando de Entendimiento con Blend Financial Services Limited

Bachmann & Welser Capital Ltd ("Bachmann & Welser"), el especialista en cartas de crédito de garantía (SBLC), financiación comercial y otros instrumentos bancarios, se complace Read mor...

Bachmann Welser Capital, proveedor de cartas de crédito de garantía/financiamiento ...

EDIMBURGO, Escocia, 2 de enero de 2018 /PRNewswire/ -- Bachmann & Welser Capital Ltd ("Bachmann & Welser"), un proveedor de financiamiento comercial internacional e instrumentos financieros...

Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson’s Pro...

SBLC- und Trade Finance-Spezialist Bachmann Welser unterzeichnet Absichtserklärung mit Blend ...

Bachmann & Welser Capital Ltd ("Bachmann & Welser"), der expandierende Spezialist für Standby Letters of Credit (SBLC), Trade Finance und andere Bankinstrumente, freut sich, die Read more...

Bachmann Welser, spécialiste mondial des lettres de crédit stand-by et du financement ...

Bachmann & Welser Capital Ltd (« Bachmann & Welser »), le spécialiste des lettres de crédit stand-by (Standby Letters of Credit - SBLC), du financement commercial et Read more...

Компания Bachmann Welser планирует представить фонд ...

     (Logo: http://mma.prnewswire.com/media/623302/Bachmann_Welser_Capital_Limited_Logo.jpg) Запуск фонда совпадёт с открытием гонконгской штаб-кв...

The Michael J. Fox Foundation for Parkinson's Research Announces Availability of $7 Million in ...

The programs opening today aim to use novel technologies to treat one of Parkinson's most serious symptoms; increase understanding and development of two leading drug Read more...

Drugs and Medications [824 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [897 Associated PubMed Articles listed on BioPortfolio]

Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.

Plantar flexion of toe dystonia is very painful and leads to difficulties in walking. The objective of this study was to investigate the effect of incobotulinum toxin A (Xeomin) in the treatment of th...

Neuronal activity patterns in the ventral thalamus: Comparison between Parkinson's disease and cervical dystonia.

The aim of this study was to distinguish neuronal activity patterns in the human ventral thalamus and reveal common and disease-specific features in patients with Parkinson's disease (PD) and cervical...

Simultaneous treatment of epilepsy and secondary dystonia after anterior temporal lobectomy and amygdalohippocampectomy.

The relationship between temporal lobe epilepsy and focal limb dystonia is a well-recognized phenomenon, yet its pathogenesis and anatomical foundation are not well understood. Here, we describe two p...

Motor sequence awareness in impaired in dystonia despite normal performance.

Dystonia is a movement disorder that has been associated with impaired motor learning and sequence recognition. However, despite evidence that patients with dystonia have a reduced sense of agency, it...

A case of undeclared debt? Claude Lévi-Strauss' ambiguities and paradoxes toward analytical psychology.

If his relationship to Sigmund Freud's psychoanalysis has been widely acknowledged, Claude Lévi-Strauss' rapport with C.G. Jung's analytical psychology remains quite obscure. While secondary commenta...

Clinical Trials [1429 Associated Clinical Trials listed on BioPortfolio]

Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

This study occurs during five visits that are already scheduled as part of "Biomarkers to Guide Directional DBS for Parkinson's Disease" (ClinicalTrials.gov Identifier: NCT03353688). If pa...

Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia

In this study, we will determine if posture and heart rate variability will significantly improve in Parkinsons disease with camptocormia after osteopathic manual treatments dystonia.

Humanitarian Device Exemption

The purpose of this study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by th...

Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome

The purpose of this study is to determine whether Mepolizumab (a monoclonal antibody against interleukin-5) is a safe and well-tolerated therapy that will allow for steroid tapering in pat...

Agency in Dystonia

In this study, using computerized cognitive assessments combined with multi-modal neuroimaging approach investigators aim to address three specific questions on patients with cervical and ...

Companies [1493 Associated Companies listed on BioPortfolio]

The Bachmann-Strauss Dystonia and Parkinson Foundation

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to...

Levi Strauss & Co.

Levi Strauss & Co. is one of the world’s largest branded apparel companies and the global leader in jeanswear, marketing its products in more than 110 countries worldwide. Th...

Dystonia Medical Research Foundation

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The F...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

More Information about "The Bachmann-Strauss Dystonia and Parkinson Foundation" on BioPortfolio

We have published hundreds of The Bachmann-Strauss Dystonia and Parkinson Foundation news stories on BioPortfolio along with dozens of The Bachmann-Strauss Dystonia and Parkinson Foundation Clinical Trials and PubMed Articles about The Bachmann-Strauss Dystonia and Parkinson Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Bachmann-Strauss Dystonia and Parkinson Foundation Companies in our database. You can also find out about relevant The Bachmann-Strauss Dystonia and Parkinson Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record